EGFR and cancer: These engineered CAR-T cells are promising in other cancers overexpressing EGFR including bladder, cervical, esophageal, head, and neck squamous cell, gastric, breast, ovarian, colorectal, endometrial, and non-small lung cell carcinomas [92,93].